The Sunnyvale, Calif.-based company produces the da Vinci SP robot-assisted surgery platform, which is cleared by the FDA for urological procedures, procedures requiring very narrow access from a single small incision and, most recently, it was cleared for single-port radical tonsillectomy and tongue base resection procedures.
Intuitive said it expects the new facility to offer education and training programs and showcase its products and services for less-invasive treatment options as well.
“Oxford is internationally renowned for medical and scientific innovation and we are proud to expand our collaboration with this community that we think will help us advance surgical innovation and improve patient outcomes,” Intuitive CEO Gary Guthart said in a news release. “Oxford Science Park provides access to world-class engineering, science, and clinical expertise that will prove valuable as we deepen our work with the clinical community and health services in the U.K. and Ireland.”
“Intuitive is expanding its presence in the U.K. and Ireland — doubling our personnel in the last 18 months — and we are excited about our plans for continued growth here,” added Intuitive U.K. and Eire vice president & general manager Phil Bradshaw.
Intuitive said it has sold more than 85 systems to hospitals in the U.K. and the Republic of Ireland.
Shares of ISRG were down -0.3% at $506.92 apiece in early-afternoon trading today.